Mesoporous Zeolitic Imidazolate Framework-67 Nanocrystals on Siliceous Mesocellular Foams for Capturing Radioactive Iodine

2020 ◽  
Vol 3 (6) ◽  
pp. 5390-5398 ◽  
Author(s):  
Le Chen ◽  
Jun-Yan Qian ◽  
Dan-Dan Zhu ◽  
Song Yang ◽  
Jian Lin ◽  
...  
Keyword(s):  
Radioactive Iodine ◽  
Zeolitic Imidazolate Framework

Amine-Functionalized Zeolitic Imidazolate Framework-8 (ZIF-8) Nanocrystals for Adsorption of Radioactive Iodine

2020 ◽  
Vol 3 (10) ◽  
pp. 9852-9861
Author(s):  
Yu Ri Lee ◽  
Xuan Huy Do ◽  
Kie Yong Cho ◽  
Keunhong Jeong ◽  
Kyung-Youl Baek
Keyword(s):  
Radioactive Iodine ◽  
Zeolitic Imidazolate Framework ◽  
Amine Functionalized

Abstract #1116 Radioactive Iodine Therapy for Graves Disease: What Predicts Failure?

2018 ◽  
Vol 24 ◽  
pp. 281-282
Author(s):  
Kalyani Regeti ◽  
Rajinikanth Yatavelli ◽  
Harsha Karanchi ◽  
Binod Pokhrel
Keyword(s):  
Radioactive Iodine ◽  
Graves Disease ◽  
Radioactive Iodine Therapy

TUMOURS OF THE HYPOPHYSIS AND THE THYROID IN MICE

1955 ◽  
Vol 18 (4) ◽  
pp. 445 ◽  
Author(s):  
O. Mühlbock
Keyword(s):  
Thyroid Gland ◽  
Radioactive Iodine ◽  
Thyroid Tissue ◽  
Prolonged Treatment ◽  
Genetic Constitution ◽  
Thiouracil Derivatives

SUMMARY Hypophyseal tumours in mice develop after prolonged treatment with oestrogens, after injection of radioactive iodine in doses which destroy the thyroid tissue and after prolonged treatment with thiouracil-derivatives. The tumours of the hypophysis only occur in certain strains of mice and hence the genetic constitution is of importance. The origin of this difference between strains has hitherto remained completely obscure. The hypophyseal tumours in mice seen following administration of oestrogens and those observed after destruction of the thyroid gland are morphologically similar. They consist of cells staining blue to varying degrees, and they may thus be termed amphophile tumours. The possible mechanism of development of the hypophyseal tumours has been discussed.

TREATMENT OF NON-TOXIC GOITRE WITH THYROID PREPARATIONS

1960 ◽  
Vol XXXIII (IV) ◽  
pp. 584-592 ◽  
Author(s):  
B.-A. Lamberg ◽  
C. A. Hernberg ◽  
Riitta Hakkila
Keyword(s):  
Radioactive Iodine ◽  
Response To Treatment ◽  
Iodine Uptake ◽  
Nodular Goitre ◽  
Radioactive Iodine Uptake ◽  
Observation Period

ABSTRACT Treatment with a thyroid preparation was used in 75 cases of non-toxic goitre. In 63 cases there was nodular goitre in 12 diffuse goitre. The observation period varied from 3 to 42 months. The size of the goitre decreased in 50 cases (68 per cent) of which 40 had a nodular goitre and 10 a diffuse goitre. In the 63 cases with a nodular goitre the size of the nodules decreased in 39 cases and the nodules disappeared completely in 2 cases (65 per cent). In 5 cases (7 per cent) there was no change in the size of the thyroid or the nodules. Temporary factitious hyperthyroidism appeared in 7 cases but subsided rapidly after adjustment of the dose. In one case an endogenous hyperthyroidism evidently developed, probably owing to initial latent hyperthyroidism. Treatment of non-toxic goitre with thyroid preparations or hormones is recommended 1) in diffuse goitre, 2) in nodular goitre as a trial and 3) after thyroidectomy for compressive goitre. The value of radioactive iodine uptake or excretion tests for the assessment of the response to treatment and the adjustment of the dose is emphasized.

Sign in / Sign up

Export Citation Format

Share Document